Cargando…

A novel isoflavone, ME-344, targets the cytoskeleton in acute myeloid leukemia

The isoflavone ME-344 is a potent anti-cancer agent with preclinical and clinical efficacy in solid tumors. Yet, the mechanism of action of ME-344 has not been fully defined and the preclinical efficacy in leukemia has not been established. Therefore, we investigated the anti-leukemic properties and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeyaraju, Danny V., Hurren, Rose, Wang, Xiaoming, MacLean, Neil, Gronda, Marcela, Shamas-Din, Aisha, Minden, Mark D., Giaever, Guri, Schimmer, Aaron D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226547/ https://www.ncbi.nlm.nih.gov/pubmed/27391350 http://dx.doi.org/10.18632/oncotarget.10446

Ejemplares similares

The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia
por: Yehudai, Dana, et al.
Publicado: (2019)

A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia
por: Reed, Gregory A., et al.
Publicado: (2016)

Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism
por: Rotin, Lianne E., et al.
Publicado: (2015)

Voltage-Dependent Anion Channels Influence Cytotoxicity of ME-344, a Therapeutic Isoflavone
por: Zhang, Leilei, et al.
Publicado: (2020)

Inhibition of SREBP1 sensitizes cells to death ligands
por: Eberhard, Yanina, et al.
Publicado: (2011)

A Novel Formulation of Tigecycline Has Enhanced Stability and Sustained Antibacterial and Antileukemic Activity
por: Jitkova, Yulia, et al.
Publicado: (2014)

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis
por: Hurrish, Katie H., et al.
Publicado: (2023)

Metabolic Adaptation to Chronic Inhibition of Mitochondrial Protein Synthesis in Acute Myeloid Leukemia Cells
por: Jhas, Bozhena, et al.
Publicado: (2013)

Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production
por: Lee, Jong Bok, et al.
Publicado: (2021)

Novel L-nucleoside analog, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia
por: Bankar, Aniket, et al.
Publicado: (2019)

Effects of a Soybean Isoflavone Mixture on Carcinogenesis in Prostate and Seminal Vesicles of F344 Rats
por: Onozawa, Mizuki, et al.
Publicado: (1999)

Suppression of Cancer Progression by MGAT1 shRNA Knockdown
por: Beheshti Zavareh, Reza, et al.
Publicado: (2012)

Transduction of Primary AML Cells with Lentiviral Vector for In Vitro Study or In Vivo Engraftment
por: Schimmer, Aaron D., et al.
Publicado: (2020)

ENOX2 Target for the Anticancer Isoflavone ME-143
por: Morré, D. James, et al.
Publicado: (2014)

IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cells
por: Nachmias, Boaz, et al.
Publicado: (2022)

The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness
por: Thomas, Geethu Emily, et al.
Publicado: (2022)

001 PP: See me, hear me, heal me: A THEATRE-BASED APPROACH TO ENGAGEMENT, CO-INTENTIONAL DIALOGUE AND MEANING-MAKING
por: Yoon, MN, et al.
Publicado: (2017)

A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity
por: Barghout, Samir H., et al.
Publicado: (2021)

The Yeast Deletion Collection: A Decade of Functional Genomics
por: Giaever, Guri, et al.
Publicado: (2014)

Isoflavones
por: Křížová, Ludmila, et al.
Publicado: (2019)

An algorithm for chemical genomic profiling that minimizes batch effects: bucket evaluations
por: Shabtai, Daniel, et al.
Publicado: (2012)

Network dynamics of the yeast methyltransferome
por: Giaever, Guri, et al.
Publicado: (2019)

Non-canonical C-terminal variant of MeCP2 R344W exhibits enhanced degradation rate
por: Chai, Yue, et al.
Publicado: (2023)

FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosing
por: Wang, Z, et al.
Publicado: (2015)

A genome-wide portrait of pervasive drug contaminants
por: Ogbede, Joseph Uche, et al.
Publicado: (2021)

Antiparasitic Effects of Selected Isoflavones on Flatworms
por: Faixová, D., et al.
Publicado: (2021)

Isoflavones and women's health
por: Powles, Trevor
Publicado: (2004)

Phase 1, Open-Label, Dose Escalation, Safety, and Pharmacokinetics Study of ME-344 as a Single Agent in Patients With Refractory Solid Tumors
por: Bendell, Johanna C, et al.
Publicado: (2015)

The Effect of Soy Isoflavones on Steroid Metabolism
por: Swart, Amanda C., et al.
Publicado: (2019)

Interactively AUDIT Your Growth Curves with a Suite of R Packages
por: Coutin, Nicolas P. J., et al.
Publicado: (2020)

The cellular response to drug perturbation is limited: comparison of large-scale chemogenomic fitness signatures
por: Barazandeh, Marjan, et al.
Publicado: (2022)

Health Tract No. 344: Marriage and Divorce
Publicado: (1868)

Source characteristics of evaporation residues and intermediate mass fragments in $Kr$ induced reactions at 26.4 and 34.4 MeV/nucleon
por: Faure-Ramstein, B, et al.
Publicado: (1994)

Enrichment of Polyglucosylated Isoflavones from Soybean Isoflavone Aglycones Using Optimized Amylosucrase Transglycosylation
por: Jung, Young Sung, et al.
Publicado: (2020)

Spatiotemporal Expression and Molecular Characterization of miR-344b and miR-344c in the Developing Mouse Brain
por: Leong, Jia-Wen, et al.
Publicado: (2016)

Soy isoflavones and virus infections
por: Andres, Aline, et al.
Publicado: (2009)

Targeting mitochondrial RNA polymerase in acute myeloid leukemia
por: Bralha, Fernando N., et al.
Publicado: (2015)

Carcinogenesis by Nitrosohydroxyethylurea and Nitrosomethoxyethylurea in F344 Rats
por: Lijinsky, William, et al.
Publicado: (1988)

344. HIV and Diabetes in the Era of Antiretroviral Therapy
por: Sabbaj. Spieler, Gabriel, et al.
Publicado: (2019)

Radiation-Induced Esophagitis is Mitigated by Soy Isoflavones
por: Fountain, Matthew D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_crtgfdh62d334re8hpnsbqqm8a